avVaa World Health Care Products Inc. Announces DRTV Media Test Launches Today

LUMBY, BC, Oct. 5 /PRNewswire-FirstCall/ - avVaa World Health Care Products
Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and
distributor of nationally branded therapeutic, natural skin and health care
products, announced the launch of its two week Neuroskin(R) Psoriasis Relief
DRTV media test campaign.
avVaa World Health Care Products Inc. announced that its two week Neuroskin(R)
Psoriasis Relief DRTV media test launched today, October 5, 2009. Over 100
informercial styled DRTV commercials will be shown on multiple networks over
the next fourteen days. The DRTV spots direct customers to purchase
Neuroskin(R) Psoriasis Relief via phone, or online at www.MyNeuroskin.com.
The Neuroskin(R) Psoriasis Relief DRTV commercials are in infomercial format
and feature a 2 minute soft offer commercial, a 2 minute hard offer
commercial, a 60 second commercial, and a 30 second commercial. The test will
determine which campaign is most successful - the hard or the soft offer. The
60 and 30 second commercials are in soft offer format, and will allow avVaa to
capitalize on free advertising spots secured by their media buyer.
"We have 102 scheduled spots over the next two week period," stated Lorie
Campbell-Farley, President and Chief Operating Officer. "When all of the
unscheduled free content is run, we anticipate we will have run over 120
commercials in total."
avVaa World Health Care Products Inc. has worked hard to ensure everything is
in place to capitalize on this second DRTV media test. "We took what we
learned from the last campaign and ran with it," commented Mrs.
Campbell-Farley, "And our great line-up of vendors had made it easy to launch
this test. Our credit card processing is running smoothly, and we have added
eCheck as a payment option. Our telemarketing call centre has provided
refresher training to its staff, and has prepared individual scripts for both
the hard and soft offers. Our distributor has 17,000 bottles of Neuroskin(R)
Psoriasis Relief in stock and ready to go."
avVaa anticipates a sales ration of at least 2:1, with two dollars in sales
for every dollar spent marketing. "With the huge internet response we had on
our first campaign, 2:1 is a conservative estimate," said Mrs.
Campbell-Farley. "This time we are set to capitalize on every web order."

The DRTV Infomercials may be previewed using the following links:
http://www.myneuroskin.com/120_hardsell_spot.html
http://www.myneuroskin.com/120_softsell_spot.html
http://www.myneuroskin.com/60_second_spot.html
http://www.myneuroskin.com/30_second_spot.html

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that
specializes in effective, all natural, therapeutic skin care products that
improve quality of life and well being for consumers. avVaa's patented
European skin care formulas are scientifically registered, FDA-Compliant, and
were developed to relieve and treat the symptoms of common skin ailments,
including eczema, psoriasis and acne. avVaa is poised to manufacture and
market its OTC Neuroskin(R) line of skin care products through mass, food and
drug channels in the United States and globally. The Company's secondary line
of equine and pet care related products are already being distributed
throughout all of Canada. For more information, visit: www.avvaa.com.

Safe Harbor: Statements contained in this press release that are not based
upon current or historical fact are forward looking in nature. Such
forward-looking statements are subject to risks and uncertainties, which could
cause actual results to differ materially from estimated results. Management
cautions that all statements as to future results of operations are
necessarily subject to risks, uncertainties, and events that may be beyond the
control of avVaa World Health Care Products, Inc. and no assurance can be
given that such results will be achieved.
Potential risks and uncertainties include but are not limited to the ability
to procure, properly price, retain, and successfully complete projects, the
availability of technical personnel, changes in technology, and competition.

CONTACT: avVaa World Health Care Products, Inquiries: info@avvaa.com; Investor
Relations: Merle Goertz, (West Coast) (604) 688-2349

SOURCE avVaa World Health Care Products

avVaa World Health Care Products, Inquiries: info@avvaa.com; Investor
Relations: Merle Goertz, (West Coast) (604) 688-2349